Related Experiment Video

Updated: Jul 6, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

[Neuroimmune regulation in children with bronchial asthma]

A A Eiubova, N G Sultanova

    Georgian Medical News
    |April 12, 2008
    PubMed

    Insights

    Neuropeptides like substance P and neurokinin A are elevated, while vasoactive intestinal peptide (VIP) is decreased in children with atopic bronchial asthma, indicating their role in the condition's development.

    Area of Science:

    • Pediatric Pulmonology
    • Neuroimmunology
    • Biochemistry

    Context:

    • Atopic bronchial asthma is a prevalent chronic respiratory condition in children.
    • The role of neuropeptides in pediatric asthma pathogenesis requires further elucidation.
    • Understanding molecular mechanisms can inform targeted therapeutic strategies.

    Purpose:

    • To investigate the levels of key neuropeptides in children with atopic bronchial asthma.
    • To compare neuropeptide concentrations between asthmatic children and a control group.
    • To assess differences in neuropeptide levels based on asthma severity (moderate vs. severe).

    Summary:

    • This study analyzed plasma levels of Substance P, neurokinin A, and vasoactive intestinal peptide (VIP) in 80 children (aged 2-14) with atopic bronchial asthma.
    • Children with asthma exhibited significantly higher levels of Substance P and neurokinin A, and lower levels of VIP compared to controls (p<0.001).
    • Similar neuropeptide alterations were observed when comparing moderate and severe asthma cases, suggesting their involvement in disease progression.

    Impact:

    • Findings suggest that neuropeptides are implicated in the pathogenesis of pediatric bronchial asthma.
    • This research may pave the way for novel diagnostic markers or therapeutic targets.
    • Highlights the neuro-immune connection in childhood asthma, emphasizing the need for integrated treatment approaches.

    More Related Videos

    Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography08:58

    Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

    Published on: July 10, 2018

    Psychophysiological Assessment of the Effectiveness of Emotion Regulation Strategies in Childhood08:09

    Psychophysiological Assessment of the Effectiveness of Emotion Regulation Strategies in Childhood

    Published on: February 11, 2017

    Related Concept Videos

    Asthma: Pathogenesis and Management01:20

    Asthma: Pathogenesis and Management

    Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
    Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
    Asthma I: Introduction01:28

    Asthma I: Introduction

    Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
    Asthma-II: Pathophysiology and Classification01:26

    Asthma-II: Pathophysiology and Classification

    Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
    Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
    Critical processes in asthma pathophysiology include:
    Asthma-I: Introduction01:29

    Asthma-I: Introduction

    Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
    Antiasthma Drugs: Leukotriene Modifiers01:19

    Antiasthma Drugs: Leukotriene Modifiers

    Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
    Leukotriene modifiers work through two distinct mechanisms:
    Asthma III: Clinical Manifestations01:13

    Asthma III: Clinical Manifestations

    Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...